recall
saveSandoz Inc recall (Cls II)
September 17, 2025updated 5mo ago
community read0 votes
Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By: Novartis Manufacturing NV, Belgium, Distributed by: Sandoz, Inc., Princeton, NJ, NDC# 0781-6186-67, Carton NDC# 0781-6186-67 — Reason: Temperature Abuse — Status: Ongoing
view source ↗Data sources
last refreshed 21m ago
Found something off?
same company · ±60 days · 6
- approvalsuccharated ferric oxide: IRON SUCROSE — FDA approvalSep 22, 2025
- approvalAZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvaldexmethylphenidate hydrochloride ER: FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvalLEUPROLIDE ACETATE: LEUPROLIDE ACETATE — FDA approvalSep 23, 2025
- recallSandoz Inc recall (Cls II)Sep 24, 2025
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugHYRIMOZ26 co-mentions · 13 sources
- drugLarotid14 co-mentions · 7 sources
- drugamoxicillin14 co-mentions · 7 sources
- drugVOQUEZNA DUAL PAK14 co-mentions · 7 sources
- drugAMOXICILLIN AND CLAVULANATE POTASSIUM14 co-mentions · 7 sources
- drugVOQUEZNA TRIPLE PAK14 co-mentions · 7 sources
- drugHUMIRA13 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that